Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
Common Stock
Additional Paid-in Capital
Deficit Accumulated During the Development Stage
Total
Beginning Balance, Amount at Dec. 31, 2012 $ 143,668 $ 79,340,666 $ (82,381,854) $ (2,897,520)
Beginning Balance, Shares at Dec. 31, 2012 143,667,570      
Common stock issued upon exercise of warrants, net, Amount 14,344 4,014,933    4,029,277
Common stock issued upon exercise of warrants, net, Shares 14,344,600      
Common stock issued for services, Amount 50 48,950    49,000
Common stock issued for services, Shares 50,000     50,000
Fair value of options and warrants issued as compensation    428,897    428,897
Fair value of warrants issued to settle payables    129,622    129,622
Fair value of warrants issued to consultants    23,251    23,251
Net loss       1,582,800 1,582,800
Ending Balance, Amount at Mar. 31, 2013 $ 158,062 $ 83,986,319 $ (80,799,054) $ 3,345,327
Ending Balance, Shares at Mar. 31, 2013 158,062,170